Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Phagenesis

- PMLiVE

Otsuka expands CNS presence with Avanir purchase

Deal for US biotech is valued at $3.5bn

- PMLiVE

The potential of regulated wearable technology

New health-tracking technologies are set to be taken seriously as medical devices

- PMLiVE

Actavis to buy Allergan for $66bn

Ends Valeant’s pursuit of Botox maker

- PMLiVE

NICE wants more evidence on skin damage technologies

But ‘spray-on-skin’ and clothes to prevent ulcers can still be used on NHS

Pharma deals during October 2014

Deal Watch: Major pharma collaborations, acquisitions and agreements in the past month

Deal Watch table for October 2014

Table listing all the major pharma mergers, acquisitions and collaborations in the past month

- PMLiVE

Actavis ‘considering’ white knight bid for Allergan

Wall Street Journal says Irish pharma company set to challenge Valeant's bid

- PMLiVE

Publicis Groupe to acquire Sapient for $3.7bn

Merger comes just months after Publicis’ failed acquisition of Omnicom

- PMLiVE

Valeant dangles higher bid in front of Allergan shareholders

Proposes $200 a share deal

- PMLiVE

AbbVie board recommends dropping Shire deal

Tells stakeholders to vote against merger in light of new rules on corporate tax

- PMLiVE

AbbVie rethinks Shire merger in light of US tax crackdown

Follows action to discourage 'inversion deals' aimed at reducing corporate tax rates

Pharma deals during September 2014

Deal Watch: Major pharma collaborations, acquisitions and agreements in the past month

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links